share_log

AI/ML Innovations Inc. Announces Settlement of Debt With ThreeD Capital Inc.

AI/ML Innovations Inc. Announces Settlement of Debt With ThreeD Capital Inc.

AI/ML Innovations Inc.宣佈與ThreeD Capital Inc.達成債務和解
Accesswire ·  03/11 14:15

TORONTO, ON / ACCESSWIRE / March 11, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FRA:42FB) announced that it has entered into a Debt Settlement and Security Agreement with ThreeD Capital Inc. (the "Creditor") of Toronto, Ontario for payment of indebtedness owing to the Creditor in the aggregate total of $27,120 with respect to services rendered by the Creditor (the "Shares for Debt Transaction"). The Creditor has agreed to the conversion of such debt into common shares of the Company (the "Common Shares"). Pursuant to the Shares for Debt Transaction, the Company will issue to the Creditor a total of 339,000 Common Shares, at a deemed price of $0.08 per Common Share. The proposed Shares for Debt Transaction is subject to the approval of the Canadian Securities Exchange.

安大略省多倫多/ACCESSWIRE/2024年3月11日/AI/ML Innovations Inc.(“AI/ML” 或 “公司”)(CSE: AIML)(OTCQB: AIMLF)(FRA: 42FB)宣佈,它已與安大略省多倫多的ThreeD Capital Inc.(“債權人”)簽訂債務清算和擔保協議,以償還欠債權人的債務總額 27,120美元,涉及債權人提供的服務(“債務交易股份”)。債權人已同意將此類債務轉換爲公司的普通股(“普通股”)。根據債務交易股份,公司將向債權人共發行339,000股普通股,認定價格爲每股普通股0.08美元。擬議的債務交易股份有待加拿大證券交易所的批准。

The Common Shares issued will be subject to a four-month hold period.

發行的普通股將有四個月的持有期。

About AI/ML Innovations Inc.

關於 AI/ML Innovations Inc.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

AI/ML Innovations Inc.調整了其業務運營,以利用新興的人工智能(AI)和機器學習(ML)領域,最初的投資重點是新興的數字健康和福祉公司,這些公司利用人工智能、機器學習、雲計算和數字平台推動變革性的醫療管理解決方案和整個健康連續體的精準支持交付。通過與Health Gauge(AIML持有95.2%的股權)、Tech2Heal(高達22%的所有權,目前由AIML持有12.44%的所有權)、AI Rx Inc.(AIML持有70%的股權)以及其他計劃中的增值投資,公司繼續利用不斷擴大的增長領域,使公司所有利益相關者受益。AI/ML的股票在加拿大證券交易所交易,代碼爲 “AIML”,OTCQB風險投資市場以 “AIMLF” 的形式交易,在法蘭克福證券交易所交易的代碼爲 “42FB”。

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

代表董事會
蒂姆·丹尼爾斯,執行主席

For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com

有關 AI/ML 創新的更多信息:
有關詳細信息,請訪問AI/ML的網站或公司提交的文件,網址爲
欲了解更多信息,請致電 (778) 405-0882 或 info@aiml-innovations.com 與 Blake Fallis 聯繫

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

CSE及其監管服務提供商(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

For AI/ML Innovations Investors

致人工智能/機器學習創新投資者

Certain statements made in this press release that are not based on historical information are forward looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives, and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events, or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at

本新聞稿中某些不基於歷史信息的聲明是前瞻性陳述,涉及大量已知和未知的風險和不確定性。本新聞稿包含與AI/ML Innovations對管理層計劃、目標和戰略(包括捍衛公司知識產權的戰略)的期望等明示或暗示的前瞻性陳述。這些陳述既不是承諾也不是擔保,但會受到各種風險和不確定性的影響,其中許多風險和不確定性是我們無法控制的,這可能導致實際結果與這些前瞻性陳述中設想的結果存在重大差異。提醒現有和潛在投資者不要過分依賴這些前瞻性陳述,這些陳述僅代表截至本文發佈之日。除非適用的證券法明確要求,否則AI/ML Innovations Inc.沒有義務更新或修改本新聞稿中包含的信息,無論是由於新信息、未來事件、情況還是其他原因。有關不確定性和風險的更多信息,可在AI/ML向證券監管機構提交的披露文件中找到,網址爲

SOURCE: AI/ML Innovations Inc.

來源:AI/ML Innovations Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論